Medical News

RSS

Study finds the cost of cancer care is skyrocketing

USA Today: "The cost of cancer treatment is 'skyrocketing' — both for individual patients and the nation, a new analysis shows. From 1990 to 2008, spending on cancer care soared to more than $90 billion from $27 billion. The increase was driven by the rising costs of sophisticated new drugs, robotic surgeries and radiation techniques, as well as the growing number of patients who are eligible to take them, says Peter Bach of New York's Memorial Sloan-Kettering Cancer Cancer, co-author of an analysis in today's Journal of the American Medical Association.

18 Mar 2010

APCER Pharma to manage pharmacovigilance strategies for six global pharmaceutical companies

APCER Pharma announced that in the past three months it has further expanded its customer base and operations. APCER is a leading global provider of comprehensive drug safety, regulatory services and risk management programs for pharmaceutical, biotechnology, medical device and consumer products companies.

18 Mar 2010

CYPHER Sirolimus-eluting Coronary Stent demonstrates efficacy advantages over Medtronic's Endeavor

Investigators reported the long-term follow-up of the largest randomized comparison between the CYPHER(R) Sirolimus-eluting Coronary Stent and Medtronic's Endeavor(R) Stent highlighting significant and sustained clinical differences. These important findings were presented at the American College of Cardiology annual meeting, (ACC 2010) in Atlanta and published on-line in the prestigious journal The Lancet.

18 Mar 2010

U.S. 'race gap' in the commission of violent crime has narrowed, yet persists in many cities: Study

The U.S. 'race gap' in the commission of violent crime has narrowed substantially, yet persists in many cities - with murder arrest rates for African Americans out-distancing those for whites - concludes a new 80-city study by the University of Maryland, Florida State University and the University of Oregon.

18 Mar 2010

BeaconEquity.com: AVI BioPharma's revenues for fourth-quarter of 2009 are $5.1M

BeaconEquity.com announces an investment report featuring biotech company AVI BioPharma Inc. The report includes financial, comparative and investment analyses, and pertinent industry information you need to know to make an educated investment decision.

18 Mar 2010

Health IT Now! Coalition panel discussion: Develop affordable access to broadband and healthcare

The Health IT Now! Coalition hosted a panel discussion today with the Federal Communications Commission and a panel of experts to discuss the FCC's National Broadband Plan and its proposals to develop affordable access to broadband and healthcare.

18 Mar 2010

Midroog rates Elbit Imaging's new series of debentures "A2/Stable"

Elbit Imaging Ltd.announced today that Midroog Ltd., an affiliate of Moody's Investors Services, has informed EI that its "A2/Stable" rating, on a local scale, would also apply to a new series of debentures in an aggregate principal amount of up to NIS 100 million that EI may issue to repay principal amounts of debt that comes due in 2010. This credit rating would also apply to additional debentures in the new series in an aggregate principal amount of up to NIS 400 million that EI may issue in exchange for outstanding debentures, subject to certain conditions.

18 Mar 2010

Achillion Pharmaceuticals receives NIH SBIR grant for study of novel antibacterial compound series

Achillion Pharmaceuticals, Inc., a leader in the discovery and development of small molecule drugs to combat the most challenging infectious diseases, today announced that it has received a Phase 1 Small Business Innovation Research Grant (SBIR) from the National Institute of Allergy and Infectious Disease (NIAID) branch of the National Institutes of Health (NIH) for the further study and characterization of a back-up series of compounds related to its novel antibacterial, ACH-702.

18 Mar 2010

ISR Reports launches new and substantial research report: Late Phase Market Dynamics

Industry Standard Research today announced the launch of a new and substantial research report titled Late Phase Market Dynamics. This report presents data and analysis from 149 interviews with decision makers from 95 unique pharmaceutical and biotechnology companies around the world.

18 Mar 2010

Modulating body's inflammatory response may help fight serious infection

Treating virulent influenza, sepsis, and other potentially deadly infections long has focused on looking for ways to kill viruses and bacteria. But new research from the University of Utah and Utah State University shows that modulating the body's own overeager inflammatory response to infection may help save more lives.

18 Mar 2010

New book exposes the ignored causes of three major life-threatening and chronic diseases

In his newest book, "Overlooked Causes and the Prevention: Cancer, Cardiovascular Heart Disease, Multiple Sclerosis" (published by AuthorHouse), author Arthur Douglass Alexander III exposes, delineates and documents the sometimes overlooked and often ignored causes of three major life-threatening and chronic diseases: cancer, cardiovascular disease and multiple sclerosis.

18 Mar 2010

AVEO Pharmaceuticals completes initial public offering of 9M common stock shares at $9.00 per share

AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced the completion of its initial public offering of 9,000,000 shares of its common stock. All shares were sold at an initial public offering price of $9.00 per share, resulting in aggregate net proceeds to AVEO of approximately $72,580,000 after deducting underwriting discounts and commissions and estimated offering expenses.

18 Mar 2010

Atrium Innovations acquires the assets of Trophic Canada for total cash consideration of $11M

Atrium Innovations Inc., a recognized leading developer, manufacturer and marketer of professionally endorsed, science-based products for the health and nutrition industry, today announced the purchase of the assets of Trophic Canada, a leading manufacturer and distributor of vitamins, minerals and herbal supplements in the Canadian Health Food Store market.

18 Mar 2010

Bleach-based disinfectants more effective against noroviruses

Some 40% of commercial disinfectants used to clean surfaces are believed to be ineffective in eliminating noroviruses, a group of viruses responsible for more than half of all foodborne gastroenteritis outbreaks. According to a recent study published by Universit- Laval researchers in the Journal of Food Protection, only bleach-based disinfectants drastically reduce the concentration of these viruses.

18 Mar 2010

InvestorSoup.com: CYCC's total revenues for third-quarter of 2009 decrease by 14%

InvestorSoup.com announces an investment report featuring Cyclacel Pharmaceuticals Inc. The report includes financial, comparative and investment analyses, and pertinent industry information you need to know to make an educated investment decision.

18 Mar 2010

ETP releases presentation highlights of 2010 Epilepsy Pipeline Update Conference

The Epilepsy Therapy Project, a non-profit organization dedicated to accelerating new therapies for people living with epilepsy, today released presentation highlights following its successful 2010 Epilepsy Pipeline Update Conference held in San Francisco. Sponsored by ETP, this conference brings together leading clinical investigators, emerging CNS companies and academic innovators with investors and business development partners to facilitate professional collaboration, funding and partnerships that will accelerate patient access to new treatments.

18 Mar 2010

Health care reform: Obama, Hispanic voters differ on priorities

Hispanic voters are troubled by the direction of the country and are very concerned about the economy, spending, debt and national security, according to a new Resurgent Republic survey. The study, released today, showed that most are responsive to fiscally conservative messages and believe that President Obama is pursuing a different main priority on health care than what they think should be the top priority.

18 Mar 2010

Health Integrated recognized with URAC accreditation for innovative health management solutions

Health Integrated, a leading provider of Health Management Solutions to health plans, has been awarded full accreditation for case management, disease management and health utilization management by URAC, a Washington, DC-based healthcare accrediting organization that establishes quality standards for the healthcare industry.

18 Mar 2010

Varian Medical Systems to showcase radiotherapy and radiosurgery solutions at medical events in Asia

Varian Medical Systems, Inc., the world's leading manufacturer of medical technology for treating cancer with radiotherapy and radiosurgery, will showcase its technology at two medical events in Asia during the month of March:

18 Mar 2010

Medical News

Study finds the cost of cancer care is skyrocketing

APCER Pharma to manage pharmacovigilance strategies for six global pharmaceutical companies

CYPHER Sirolimus-eluting Coronary Stent demonstrates efficacy advantages over Medtronic's Endeavor

U.S. 'race gap' in the commission of violent crime has narrowed, yet persists in many cities: Study

BeaconEquity.com: AVI BioPharma's revenues for fourth-quarter of 2009 are $5.1M

Health IT Now! Coalition panel discussion: Develop affordable access to broadband and healthcare

Midroog rates Elbit Imaging's new series of debentures "A2/Stable"

Achillion Pharmaceuticals receives NIH SBIR grant for study of novel antibacterial compound series

ISR Reports launches new and substantial research report: Late Phase Market Dynamics

Modulating body's inflammatory response may help fight serious infection

New book exposes the ignored causes of three major life-threatening and chronic diseases

AVEO Pharmaceuticals completes initial public offering of 9M common stock shares at $9.00 per share

Atrium Innovations acquires the assets of Trophic Canada for total cash consideration of $11M

Bleach-based disinfectants more effective against noroviruses

InvestorSoup.com: CYCC's total revenues for third-quarter of 2009 decrease by 14%

ETP releases presentation highlights of 2010 Epilepsy Pipeline Update Conference

Health care reform: Obama, Hispanic voters differ on priorities

Health Integrated recognized with URAC accreditation for innovative health management solutions

Varian Medical Systems to showcase radiotherapy and radiosurgery solutions at medical events in Asia

Popular home video game system modified to help teenagers with cerebral palsy improve hand functions

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News